NOVEL CD4+ T CELL COSTIMULATORY MOLECULE IN EAE
NOVEL CD4+ T CELL COSTIMULATORY MOLECULE IN EAE
批准号:
2750939
负责人:
Andrew D Weinberg
金额:
$17.91万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-09-30 至 1999-07-31
中文摘要
描述(改编自研究者摘要):在…过程中
英文摘要
DESCRIPTION (Adapted from Investigator's abstract): In the course of
examining cells isolated from rats with clinical signs of EAE, the
principal investigator noted the presence of a cell surface marker
(OX40) on CNS-resident T-cells. This antigen, a member of the TNF-R
family, was for the most part exclusively expressed on MBP-specific T-
cells and primarily on those that had homed to the CNS, leading the
principal investigator to propose in this new R01 that OX40 is key
surface molecule on EAE-effector cells. His plan is to assess the
biological significance of the OX40 expression, using anti-OX40 reagents
to define recently activated T-cells in the inflammatory site, to
costimulate these cells via their OX40 receptor, to identify the OX40
ligand within the target CNS tissue, to prepare an immunotoxin and use
it in a demyelinating relapsing EAE model, to characterize human OX-40
expression in MS, and finally, to characterize the in vivo significance
of OX40 on CD4 T-cells by creating a mouse knockout for this receptor.
The identification of EAE-selective markers on T-cells is a very
worthwhile goal, given the state of the art in immunosuppressive
therapies for MS, and the particular approach presented in this
application is rational, timely, and within the scope of the skills of
this investigator.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4049/jimmunol.162.3.1818
发表时间:
1999-02
期刊:
Journal of immunology
影响因子:
4.4
作者:
[A. Weinberg;Keith W. Wegmann;Castle J. Funatake;Ruth H. Whitham]
通讯作者:
A. Weinberg;Keith W. Wegmann;Castle J. Funatake;Ruth H. Whitham
The Importance of T cell Survival in Tumor Immunity
-
批准号:7267310
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2007
-
负责人:Andrew D Weinberg
-
依托单位:
The Importance of T cell Survival in Tumor Immunity
-
批准号:8020895
-
项目类别:
-
资助金额:$26.23万
-
财政年份:2007
-
负责人:Andrew D Weinberg
-
依托单位:
The Importance of T cell Survival in Tumor Immunity
-
批准号:7759639
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2007
-
负责人:Andrew D Weinberg
-
依托单位:
The Importance of T cell Survival in Tumor Immunity
-
批准号:7391821
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2007
-
负责人:Andrew D Weinberg
-
依托单位:
The Importance of T cell Survival in Tumor Immunity
-
批准号:7555038
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2007
-
负责人:Andrew D Weinberg
-
依托单位:
To Understand/Augment OX40-mediated Tumor Immunotherapy
-
批准号:8070502
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2003
-
负责人:Andrew D Weinberg
-
依托单位:
To Understand/Augment OX40-mediated Tumor Immunotherapy
-
批准号:7089030
-
项目类别:
-
资助金额:$30.92万
-
财政年份:2003
-
负责人:Andrew D Weinberg
-
依托单位:
To Understand/Augment OX40-mediated Tumor Immunotherapy
-
批准号:7227428
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2003
-
负责人:Andrew D Weinberg
-
依托单位:
To Understand/Augment OX40-mediated Tumor Immunotherapy
-
批准号:6762363
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2003
-
负责人:Andrew D Weinberg
-
依托单位:
To Understand/Augment OX40-mediated Tumor Immunotherapy
-
批准号:8465111
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2003
-
负责人:Andrew D Weinberg
-
依托单位:
To Understand/Augment OX40-mediated Tumor Immunotherapy
-
批准号:6676730
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2003
-
负责人:Andrew D Weinberg
-
依托单位:
To Understand/Augment OX40-mediated Tumor Immunotherapy
-
批准号:7860496
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2003
-
负责人:Andrew D Weinberg
-
依托单位:
To Understand/Augment OX40-mediated Tumor Immunotherapy
-
批准号:7755849
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2003
-
负责人:Andrew D Weinberg
-
依托单位:
To Understand/Augment OX40-mediated Tumor Immunotherapy
-
批准号:8255363
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2003
-
负责人:Andrew D Weinberg
-
依托单位:
To Understand/Augment OX40-mediated Tumor Immunotherapy
-
批准号:6911614
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2003
-
负责人:Andrew D Weinberg
-
依托单位:
USING NOVEL TNF RECEPTORS TO ENHANCE IMMUNOTHERAPY
-
批准号:6377145
-
项目类别:
-
资助金额:$17.9万
-
财政年份:1999
-
负责人:Andrew D Weinberg
-
依托单位:
USING NOVEL TNF RECEPTORS TO ENHANCE IMMUNOTHERAPY
-
批准号:2839714
-
项目类别:
-
资助金额:$16.87万
-
财政年份:1999
-
负责人:Andrew D Weinberg
-
依托单位:
USING NOVEL TNF RECEPTORS TO ENHANCE IMMUNOTHERAPY
-
批准号:6174294
-
项目类别:
-
资助金额:$17.38万
-
财政年份:1999
-
负责人:Andrew D Weinberg
-
依托单位:
USING NOVEL TNF RECEPTORS TO ENHANCE IMMUNOTHERAPY
-
批准号:6513553
-
项目类别:
-
资助金额:$18.44万
-
财政年份:1999
-
负责人:Andrew D Weinberg
-
依托单位:
NOVEL CD4+ T CELL COSTIMULATORY MOLECULE IN EAE
-
批准号:2460652
-
项目类别:
-
资助金额:$17.23万
-
财政年份:1995
-
负责人:Andrew D Weinberg
-
依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
-
批准号:61602201
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:周雄辉
-
依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
-
批准号:81170309
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:颜桥
-
依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
-
批准号:30672394
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:陆豪杰
-
依托单位: